Ipca Laboratories Limited (NSE:IPCALAB)
India · Delayed Price · Currency is INR 1,434.60
-5.20 (-0.36%)
Dec 29, 2025, 3:29 PM IST
Ipca Laboratories Market Cap
Ipca Laboratories has a market cap or net worth of 365.28 billion as of December 29, 2025. Its market cap has decreased by -5.51% in one year.
Market Cap
365.28B
Enterprise Value
379.91B
Revenue
93.59B
Ranking
n/a
PE Ratio
42.68
Stock Price
1,434.60
Market Cap Chart
Since June 12, 2002, Ipca Laboratories's market cap has increased from 3.22B to 365.28B, an increase of 11,248.61%. That is a compound annual growth rate of 22.25%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 26, 2025 | 365.28B | -15.07% |
| Dec 31, 2024 | 430.08B | 52.29% |
| Dec 29, 2023 | 282.41B | 32.03% |
| Dec 30, 2022 | 213.90B | -22.18% |
| Dec 31, 2021 | 274.86B | -1.01% |
| Dec 31, 2020 | 277.65B | 93.40% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sun Pharmaceutical Industries | 4.17T |
| Divi's Laboratories | 1.71T |
| Cipla | 1.21T |
| Apollo Hospitals Enterprise | 1.03T |
| Zydus Lifesciences | 923.52B |
| Mankind Pharma | 905.28B |
| Aurobindo Pharma | 703.58B |
| Fortis Healthcare | 681.50B |